← Back to Search

Behavioural Intervention

Immersive Virtual Reality for Chronic Pain

N/A
Waitlist Available
Led By Nancy A Baker
Research Sponsored by Tufts University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up completed immediately after ivr experience
Awards & highlights

Study Summary

This trial is examining whether or not IVR can help chronic low back pain patients who use opioids by looking at changes in their sensory and pain perceptions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~completed immediately after ivr experience
This trial's timeline: 3 weeks for screening, Varies for treatment, and completed immediately after ivr experience for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PANAS
Quantitative sensory testing (QST): Mechanical Pressure Pain Thresholds (MPPTh)
Quantitative sensory testing (QST): Mechanical Temporal Summation of Pain (MTSP)
+1 more
Secondary outcome measures
IGroup Presence Questionnaire
Simulator Sickness Questionnaire

Trial Design

1Treatment groups
Experimental Treatment
Group I: All participantsExperimental Treatment1 Intervention
Quantitative sensory testing will be completed and current pain levels obtained. 20-minutes of immersive virtual reality will be completed, and then complete quantitative sensory testing again. We will compare pre-IVR quantitative sensory testing with post IVR levels.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Immersive Virtual Reality
2021
N/A
~110

Find a Location

Who is running the clinical trial?

Tufts UniversityLead Sponsor
263 Previous Clinical Trials
661,774 Total Patients Enrolled
Brigham and Women's HospitalOTHER
1,608 Previous Clinical Trials
11,469,877 Total Patients Enrolled
19 Trials studying Chronic Pain
1,781 Patients Enrolled for Chronic Pain
Nancy A BakerPrincipal InvestigatorTufts University
2 Previous Clinical Trials
25 Total Patients Enrolled

Media Library

Immersive Virtual Reality (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04609787 — N/A
Chronic Pain Research Study Groups: All participants
Chronic Pain Clinical Trial 2023: Immersive Virtual Reality Highlights & Side Effects. Trial Name: NCT04609787 — N/A
Immersive Virtual Reality (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04609787 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial accept participants aged 45 or older?

"This medical trial is open to individuals aged between 25 and 65 years old."

Answered by AI

How many participants are involved in this clinical exploration?

"Indeed, the information hosted on clinicaltrials.gov confirms that this medical research is in search of volunteers. It was first published on May 5th 2021 and updated as recently as December 1st 2022. 20 participants are required from a single centre for completion of the trial."

Answered by AI

Are there still opportunities to join this experiment?

"Affirmative. According to clinicaltrials.gov, the research project was first published on May 1st 2021 and has since been updated as recently as December 1st 2022. Currently, 20 participants are needed from a single study centre for this trial's completion."

Answered by AI

For whom is enrollment in this medical experiment permissible?

"This clinical trial is seeking 20 volunteers suffering from chronic pain with ages ranging between 25 and 65 to participate. To qualify, applicants must meet the following criteria: age bracket of 25-65 years old; primary complaint of continuous lower back pain for six months or longer; usual severity rating on a visual analog scale score ≥ 4/10; currently prescribed opioids therapy under consideration for dose reduction by their physician; ability to communicate in English verbally and comprehend it."

Answered by AI
~0 spots leftby Apr 2025